Rambam Medical Center
Haifa, Israel
NCT Number: NCT03748472
SpO2 instability is in the nature of premature infants. Hypoxic episodes occur spontaneously in many of these infants, especially after the first week of life. Different interventions have been shown to influence the incidence of hypoxemic episodes in premature infants. Premature infants are fed via an NG/OG tube. Feeding length might influence the oxygenation instability among premature infants therefore the aim of this study is to evaluate the changes in oxygenation among preterm infants receiving respiratory support when are fed over 30 min vs over 2 hours, as documented by SpO2 histograms.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Haifa, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Premature Infants (GA<37weeks) on non-invasive respiratory support (CPAP, NIPPV, HFNC) Feeding>100 ml/kg/day
Exclusion criteria
Congenital anomalies e.g. gastroschesis, congenital diaphragmatic hernia, cyanotic heart disease.
Instability because of:
Acute lung pathology for example x-ray confirmed pneumonia, air leak Active culture proven sepsis Need for inotropic support for low blood pressure
Each subject will serve as his or her own control. In this arm infants will receive their feed over 2 hours and the next feed will be given over 30 min and then over 2 hours again.
Each subject will serve as his or her own control. In this arm infants will receive their feed over 30 min and the next feed will be given over 2 hours and then over 30 minutes again.
Time frame: 9 hours (3 feeds)
SPO2 histogram documents the oxygenation stability. we will record the histogram at the end of each period of time and compare it
Rambam Health Care Campus
Other
The Effects of Bolus Feeding as Compared to Continuous Gavage Feeding on the Oxygenation Instability During Feeds Among Premature Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03114644
Female Urogenital Diseases and Pregnancy Complications, Mother-Baby Synchrony
Amiens, Picardie, France
View Trial DetailsNCT03093337
Cognition Disorders, Cognitive Dysfunction
Albi, Midi-Pyrénées, France
View Trial DetailsNCT02184650
Delayed Mental Development, Female Urogenital Diseases and Pregnancy Complications
Paris, France
View Trial DetailsNCT06959290
Agnosia, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial Details